Newall F, Johnston L, Ignjatovic V, Summerhayes R, Monagle P
Department of Pathology, The University of Melbourne, Melbourne, Australia.
Int J Lab Hematol. 2009 Aug;31(4):457-61. doi: 10.1111/j.1751-553X.2008.01055.x. Epub 2008 Mar 21.
Current clinical recommendations for unfractionated heparin (UFH) therapy suggest target APTT ranges should reflect heparin concentrations of 0.2-0.4 IU/ml by protamine titration or 0.35-0.7 IU/m by an anti-Xa assay. Historically, performance of a manual protamine titration assay has been labour intensive and required a large plasma sample. However, recent studies have described difficulties with standardizing anti-Xa assays and demonstrated poor correlation of anti-Xa assays in children. This study aimed to refine and test the feasibility of a modified protamine titration assay using 100 microl of plasma. The resultant method produced reliable and repeatable results in adult plasma pools spiked with UFH. The feasibility of this method was proven by testing of in vivo heparinised samples obtained from children. This protamine titration method may offer an alternative to anti-Xa assays for clinical monitoring of children on heparin therapy, and will enhance clinical studies investigating paediatric-specific management of UFH therapy.
目前关于普通肝素(UFH)治疗的临床建议表明,通过鱼精蛋白滴定法,目标活化部分凝血活酶时间(APTT)范围应反映肝素浓度为0.2 - 0.4 IU/ml,或通过抗Xa测定法反映为0.35 - 0.7 IU/ml。从历史上看,手动鱼精蛋白滴定法操作起来劳动强度大,且需要大量血浆样本。然而,最近的研究描述了标准化抗Xa测定法存在的困难,并表明抗Xa测定法在儿童中的相关性较差。本研究旨在改进并测试一种使用100微升血浆的改良鱼精蛋白滴定法的可行性。所得方法在添加了UFH的成人血浆样本中产生了可靠且可重复的结果。通过对从儿童获得的体内肝素化样本进行检测,证明了该方法的可行性。这种鱼精蛋白滴定法可能为肝素治疗儿童的临床监测提供一种替代抗Xa测定法的方法,并将加强研究UFH治疗儿科特定管理的临床研究。